SG11201704791WA - Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof - Google Patents
Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereofInfo
- Publication number
- SG11201704791WA SG11201704791WA SG11201704791WA SG11201704791WA SG11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA SG 11201704791W A SG11201704791W A SG 11201704791WA
- Authority
- SG
- Singapore
- Prior art keywords
- azepine
- dipropyl
- carboxamide
- pyrrolidine
- benzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462092764P | 2014-12-16 | 2014-12-16 | |
PCT/US2015/065755 WO2016100302A2 (en) | 2014-12-16 | 2015-12-15 | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201704791WA true SG11201704791WA (en) | 2017-07-28 |
Family
ID=56127832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201704791WA SG11201704791WA (en) | 2014-12-16 | 2015-12-15 | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof |
Country Status (12)
Country | Link |
---|---|
US (2) | US20190100512A1 (en) |
EP (1) | EP3233088A4 (en) |
JP (2) | JP6707088B2 (en) |
KR (1) | KR20170118700A (en) |
AU (1) | AU2015362720B2 (en) |
BR (1) | BR112017012646A2 (en) |
CA (1) | CA2970358A1 (en) |
EA (1) | EA201791346A1 (en) |
IL (1) | IL252744A0 (en) |
MX (1) | MX2017007955A (en) |
SG (1) | SG11201704791WA (en) |
WO (1) | WO2016100302A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201704791WA (en) | 2014-12-16 | 2017-07-28 | Celgene Corp | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof |
EP3595668B1 (en) | 2017-03-15 | 2021-07-21 | Silverback Therapeutics, Inc. | Benzazepine compounds, conjugates, and uses thereof |
CN109320456A (en) * | 2018-11-16 | 2019-02-12 | 天津商业大学 | Antitumoral compounds of novel crystal forms and preparation method thereof and composition containing it |
EP4106819A1 (en) | 2020-02-21 | 2022-12-28 | Silverback Therapeutics, Inc. | Nectin-4 antibody conjugates and uses thereof |
WO2022006327A1 (en) | 2020-07-01 | 2022-01-06 | Silverback Therapeutics, Inc. | Anti-asgr1 antibody conjugates and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
IT1229203B (en) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS. |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
IT1270594B (en) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN |
CZ20022332A3 (en) * | 2000-01-07 | 2003-01-15 | Transform Pharmaceuticals, Inc. | Sample assembly |
TW201402124A (en) | 2005-08-19 | 2014-01-16 | Array Biopharma Inc | 8-substituted benzoazepines as toll-like receptor modulators |
DK2313111T3 (en) * | 2008-08-01 | 2013-12-02 | Ventirx Pharmaceuticals Inc | Toll-like receptor agonist formulations and their use |
EP2358683B1 (en) | 2008-11-06 | 2015-04-01 | VentiRx Pharmaceuticals, Inc. | Methods of synthesis of benzazepine derivatives |
WO2012045089A2 (en) * | 2010-10-01 | 2012-04-05 | Ventirx Pharmaceuticals, Inc. | Methods for the treatment of allergic diseases |
SG11201704791WA (en) | 2014-12-16 | 2017-07-28 | Celgene Corp | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof |
-
2015
- 2015-12-15 SG SG11201704791WA patent/SG11201704791WA/en unknown
- 2015-12-15 US US15/537,331 patent/US20190100512A1/en not_active Abandoned
- 2015-12-15 EP EP15870852.9A patent/EP3233088A4/en not_active Withdrawn
- 2015-12-15 MX MX2017007955A patent/MX2017007955A/en active IP Right Grant
- 2015-12-15 KR KR1020177019310A patent/KR20170118700A/en unknown
- 2015-12-15 AU AU2015362720A patent/AU2015362720B2/en not_active Ceased
- 2015-12-15 JP JP2017532617A patent/JP6707088B2/en not_active Expired - Fee Related
- 2015-12-15 BR BR112017012646-0A patent/BR112017012646A2/en not_active Application Discontinuation
- 2015-12-15 WO PCT/US2015/065755 patent/WO2016100302A2/en active Application Filing
- 2015-12-15 EA EA201791346A patent/EA201791346A1/en unknown
- 2015-12-15 CA CA2970358A patent/CA2970358A1/en not_active Abandoned
-
2017
- 2017-06-07 IL IL252744A patent/IL252744A0/en unknown
-
2019
- 2019-09-13 US US16/570,191 patent/US10604510B2/en not_active Expired - Fee Related
-
2020
- 2020-01-31 JP JP2020014267A patent/JP2020079261A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200002316A1 (en) | 2020-01-02 |
BR112017012646A2 (en) | 2018-01-02 |
EA201791346A1 (en) | 2018-01-31 |
US10604510B2 (en) | 2020-03-31 |
WO2016100302A3 (en) | 2016-09-15 |
JP6707088B2 (en) | 2020-06-10 |
EP3233088A4 (en) | 2018-09-19 |
CA2970358A1 (en) | 2016-06-23 |
AU2015362720A1 (en) | 2017-07-06 |
JP2020079261A (en) | 2020-05-28 |
WO2016100302A2 (en) | 2016-06-23 |
MX2017007955A (en) | 2018-02-19 |
US20190100512A1 (en) | 2019-04-04 |
JP2017537962A (en) | 2017-12-21 |
EP3233088A2 (en) | 2017-10-25 |
KR20170118700A (en) | 2017-10-25 |
IL252744A0 (en) | 2017-08-31 |
AU2015362720B2 (en) | 2019-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272089B1 (en) | Compounds, compositions and methods | |
IL276695B (en) | Antibodies, pharmaceutical compositions and uses thereof | |
ZA201605210B (en) | Thermoassociative and exchangeable copolymers, and compositions comprising same | |
HUE062446T2 (en) | Compounds, compositions and methods | |
EP3179870C0 (en) | Antimicrobial compounds and compositions, and uses thereof | |
IL249646A0 (en) | Platinum compounds, compositions, and uses thereof | |
GB201423376D0 (en) | Antimicrobial compounds, compositions and methods | |
IL247319A0 (en) | Triazine compounds, compositions comprising same and uses thereof | |
IL252744A0 (en) | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof | |
PL3223796T3 (en) | Pharmaceutical compositions, preparation and uses thereof | |
PT3552017T (en) | Compounds, compositions and methods | |
IL252397A0 (en) | Pharmaceutical composition, preparation and uses thereof | |
IL252897A0 (en) | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | |
IL248783A0 (en) | Quencher compounds, compositions comprisingsame and uses thereof | |
IL290114A (en) | Pharmaceutical composition, preparation and uses thereof | |
EP3313393A4 (en) | Platinum compounds, compositions, and uses thereof | |
IL248256B (en) | Cyclohexenyl compounds, compositions comprising them and uses thereof | |
PL3229843T3 (en) | Pharmaceutical composition, preparation and uses thereof | |
EP3148996A4 (en) | C2-carbocyclic iminothiazine dioxides as bace inhibitors, compositions, and their use | |
IL270505B1 (en) | Compounds, compositions and methods | |
EP3237399A4 (en) | Compounds, compositions and methods | |
GB201513614D0 (en) | Compositions, compounds and methods and uses relating thereto | |
EP3194396A4 (en) | Diazine-fused amidine compounds as bace inhibitors, compositions, and their use | |
EP3191447A4 (en) | S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use | |
EP3313392A4 (en) | Platinum compounds, compositions, and uses thereof |